Previous close | 0.0300 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 7.50 |
Expiry date | 2024-10-18 |
Day's range | 0.0300 - 0.0300 |
Contract range | N/A |
Volume | |
Open interest | 2 |
KARL STORZ to acquire Asensus for $0.35 per share in cash Creating a leading surgical robotics division within KARL STORZ RESEARCH TRIANGLE PARK, N.C., June 07, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) (“Asensus Surgical” or “Asensus”), a global leader of innovative digital solutions for the operating room, today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with KARL STORZ Endoscopy-America, Inc. ("KARL STORZ"), a wholly o
Despite a slight revenue increase and strategic partnerships, Asensus Surgical faces ongoing financial hurdles and potential acquisition uncertainties.
RESEARCH TRIANGLE PARK, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced its operating and financial results for the first quarter 2024. Recent Highlights Announced non-binding acquisition proposal and exclusivity arrangement with KARL STORZ SE & Co. KG (KARL STORZ)KARL STORZ to provide up to $20 million in financingNearly 900 procedures performed globally during the quarterOne S